Hyperammonemia in urea cycle disorders: role of the nephrologist (Q34234227)

31 July 2017

1 reference

title

Hyperammonemia in urea cycle disorders: role of the nephrologist (English)

1 reference

31 July 2017

Mathias RS

1

1 reference

31 July 2017

Kostiner D

series ordinal

2

1 reference

31 July 2017

Packman S

series ordinal

3

1 reference

31 July 2017

publication date

1 May 2001

1 reference

American Journal of Kidney Diseases

31 July 2017

published in

1 reference

31 July 2017

volume

37

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

1069-1080

1 reference

Inherited and acquired syndromes of hyperammonemia and encephalopathy in children

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Hyperammonemia: the silent killer.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Ornithine transcarbamylase deficiency: adult onset of severe symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Inborn errors of metabolism and Reye syndrome: differential diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Roles of neuroactive amino acids in ammonia neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Glial fibrillary acidic protein and cartilage

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Ornithine carbamoyl transferase deficiency: a neuropathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Neurological features and computed tomography of the brain in children with ornithine carbamoyl transferase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Effects of hyperammonaemia on brain function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Long-term survival of patients with argininosuccinate synthetase deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Prospective treatment of urea cycle disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Late onset ornithine carbamoyl transferase deficiency in males

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Hyperammonemia in women with a mutation at the ornithine carbamoyltransferase locus. A cause of postpartum coma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Vomiting, ataxia, and altered mental status in an adolescent: late-onset ornithine transcarbamylase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Comparison of exchange transfusion, peritoneal dialysis, and hemodialysis for the treatment of hyperammonemia in an anuric newborn infant

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

The management of life-threatening hyperammonemia: a comparison of several therapeutic modalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Hemodialysis catheter placement and recirculation in treatment of hyperammonemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Determinants of ammonia clearance by hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Peritoneal dialysis in the treatment of metabolic crises caused by inherited disorders of organic and amino acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Neonatal hemodialysis: effective therapy for the encephalopathy of inborn errors of metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Continuous venovenous hemofiltration in the management of acute decompensation in inborn errors of metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Continuous venovenous haemofiltration in the acute treatment of inborn errors of metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Effective hemodialysis and hemofiltration driven by an extracorporeal membrane oxygenation pump in infants with hyperammonemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Dialysis in neonates with inborn errors of metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Ammonia clearance by peritoneal dialysis and continuous arteriovenous hemodiafiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Three cases of intravenous sodium benzoate and sodium phenylacetate toxicity occurring in the treatment of acute hyperammonaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Alternative pathway therapy for urea cycle disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Novel strategies for liver support in acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Review of support systems used in the management of fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Liver transplantation for the treatment of urea cycle disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

Severe transient neonatal hyperammonemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2805%2980026-5

7 January 2021

10.1016/S0272-6386(05)80026-5

Identifiers

DOI

1 reference

31 July 2017

1 reference